; and (BB) training with respect to any other best practice the Secretary determines should be included in the curriculum, which may include training on pain management, including assessment and appropriate use of opioid and non-opioid alternatives. . (b) Treatment for children The Secretary of Health and Human Services shall consider ways to ensure that an adequate number of qualified practitioners, as defined in subparagraph (G)(ii) of section 303(g)(2) of the Controlled Substances Act ( 21 U.S.C. 823(g)(2) ), who have a specialty in pediatrics or the treatment of children or adolescents, are granted a waiver under such section 303(g)(2) to treat children and adolescents with substance use disorders. (c) Technical Amendment Section 102(24) of the Controlled Substances Act ( 21 U.S.C. 802(24) ) is amended by striking Health, Education, and Welfare and inserting Health and Human Services . 3203. Grants to enhance access to substance use disorder treatment (a) In general The Secretary of Health and Human Services shall establish a grant program under which the Secretary may make grants to accredited schools of allopathic medicine or osteopathic medicine and teaching hospitals located in the United States to support the development of curricula that meet the requirements under subclause (VIII) of section 303(g)(2)(G)(ii) of the Controlled Substances Act, as added by section 3202(a) of this Act. (b) Authorization of appropriations There is authorized to be appropriated, for grants under subsection (a), $4,000,000 for each of fiscal years 2019 through 2023. 3204. Delivery of a controlled substance by a pharmacy to be administered by injection or implantation (a) In general The Controlled Substances Act is amended by inserting after section 309 ( 21 U.S.C. 829 ) the following: 309A. Delivery of a controlled substance by a pharmacy to an administering practitioner (a) In general Notwithstanding section 102(10), a pharmacy may deliver a controlled substance to a practitioner in accordance with a prescription that meets